Insider · CIK 0001471956

Pernock David

CIK 0001471956 Name as filed on the most recent filing

Filed as Pernock David (12)

13 transaction lines · from 12 filings · filed 2013-11-21 to 2017-05-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

13 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2017-05-19 P, Open-market purchase Eagle Pharmaceuticals, Inc.EGRX 20,321, acquired Open Form 4 filing 0001209191-17-033952
2017-05-16 P, Open-market purchase Eagle Pharmaceuticals, Inc.EGRX 16,448, acquired Open Form 4 filing 0001209191-17-032825
2017-03-21 P, Open-market purchase Eagle Pharmaceuticals, Inc.EGRX 5,123, acquired Open Form 4 filing 0001209191-17-022052
2017-03-09 P, Open-market purchase Eagle Pharmaceuticals, Inc.EGRX 35,028, acquired Open Form 4 filing 0001209191-17-019959
2016-12-02 P, Open-market purchase Fibrocell Science, Inc.FCSC 46,085, acquired Open Form 4 filing 0000357097-16-000202
2015-11-13 P, Open-market purchase Fibrocell Science, Inc.FCSC 14,997, acquired Open Form 4 filing 0000357097-15-000108
2015-08-11 P, Open-market purchase Fibrocell Science, Inc.FCSC 22,890, acquired Open Form 4 filing 0000357097-15-000090
2015-05-13 P, Open-market purchase Fibrocell Science, Inc.FCSC 2 lines 71,347, acquired Open Form 4 filing 0001192482-15-000188
2014-12-12 P, Open-market purchase Fibrocell Science, Inc.FCSC 12,600, acquired Open Form 4 filing 0001445305-14-005557
2014-11-20 P, Open-market purchase Fibrocell Science, Inc.FCSC 12,686, acquired Open Form 4 filing 0001192482-14-000242
2014-06-05 P, Open-market purchase Fibrocell Science, Inc.FCSC 36,925, acquired Open Form 4 filing 0001192482-14-000095
2013-11-21 P, Open-market purchase Fibrocell Science, Inc.FCSC 36,900, acquired Open Form 4 filing 0001181431-13-060141

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
O, Officer
Officer
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 13
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Pernock David, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001471956

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.